Skip to main content

Day: December 15, 2020

ERES REIT Continues Growth With €12mm Multi-Residential Acquisition in the Netherlands

TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX:ERE.UN, “ERES” or the “REIT”) announced today that it has entered into an agreement to acquire a multi-residential property located in Steenwijk, a city in the Dutch province of Overijssel (the “Steenwijk Property”). The building is comprised of 98 residential units which are 100% owned and currently 98% leased.The €12.25 million (C$19 million) purchase price (excluding transaction costs and fees) represents an estimated forward capitalization rate of approximately 4.1%, and closing is anticipated on or around December 29, 2020. The Steenwijk Property is the fourth acquisition by ERES over the course of Q3 and Q4 2020, bringing total acquisition volume to €81 million (excluding transaction costs and fees) and increasing aggregate suite...

Continue reading

Whitestone Added 9,000 Square Feet of New Tenants at Shops of Starwood Increasing NOI by 16% at the Center and Capitalizing on the Supercharged Growth in Frisco, TX

HOUSTON, Dec. 15, 2020 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) continues to grow occupancy by drawing expanding businesses to its properties located in the high growth markets of Frisco, TX and other surrounding areas of Dallas.Continuing its resiliency despite the pandemic, Whitestone is pleased to announce local realtors Re/Max DFW Associates and United Real Estate Dallas are opening at The Shops of Starwood to expand their businesses and capture additional market share from the national trend of businesses and consumers fleeing high tax, high regulatory cities for the business-friendlier confines of Dallas and its surrounding communities. These additions increase occupancy at the center to 100%, and will contribute 16% additional NOI in 2021.According to Bisnow, recent corporate moves to the DFW area are:PGAMcKessonCharles...

Continue reading

Hammer Fiber Optics Holdings Corp Announces Financial Results for Quarter Ended October 31, 2020

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) —  Hammer Fiber Optics Holdings Corp (OTCQB: HMMR) announced operating and financial results for the fiscal quarter ended October 31, 2020.Key results include:Total revenues for the quarter were $484,842, increasing over the fourth quarter of Fiscal 2019. The increase was due to strong performance from Hammer’s SMS messaging practice.EBITDA (non-GAAP) loss for the quarter decreased to $15,572. The company had positive cash flows in the final month of the quarter (unaudited) and anticipates positive cash flow on a forward-looking basis.Development of the HammerCall video conferencing product has now been completed, and final versions of the mobile applications for IOS and Android will be available in December. Hammer intends to pursue direct sales as well as sales through multiple white label...

Continue reading

Gilead  and  Galapagos  announce  New  Commercialization  and  Development  Agreement  for  Jyseleca®  (filgotinib)  

— Gilead will Not Advance Jyseleca for the Treatment of Rheumatoid Arthritis (RA) in the U.S. Following FDA Type A Meeting —— Galapagos to Assume Sole Responsibility in Europe for Jyseleca in RA and Ulcerative Colitis (UC) Plus Future Indications; Gilead to Receive Royalties on European Sales Starting in 2024 —— Galapagos to Assume Responsibility for Majority of Ongoing Clinical Trials —— Gilead will Pay Galapagos €160 million to Support Ongoing Development and Accelerated Commercial Buildout in EU —Galapagos webcast presentation tomorrow, 16 December 2020, at 14:00 CET / 8 AM ET,www.glpg.com +32 2 793 38 47, code 7689939Foster City, Calif., and Mechelen, Belgium, December 15, 2020, 22.15 CET; regulated information – Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & Nasdaq:...

Continue reading

GILEAD EN GALAPAGOS KONDIGEN NIEUWE COMMERCIALISERING EN ONTWIKKELINGSOVEREENKOMST AAN VOOR JYSELECA® (FILGOTINIB)

— Na FDA Type A-bijeenkomst zal Gilead niet doorgaan met Jyseleca voor de behandeling van reumatoïde artritis (RA) in de VS —— Galapagos wordt volledig verantwoordelijk voor Jyseleca bij RA en colitis ulcerosa (CU) en toekomstige indicaties in Europa; Gilead ontvangt vanaf 2024 royalty’s voor Europese verkopen —— Galapagos zal verantwoordelijk zijn voor de meerderheid van lopende klinische studies —— Gilead zal €160 miljoen aan Galapagos betalen om lopende ontwikkeling en versnelde commerciële uitbouw in EU te ondersteunen —Galapagos webcast presentatie morgen, 16 december 2020, om 14:00 CET / 8 AM ET,www.glpg.com , +32 2 793 38 47, code 7689939Foster City, Calif., en Mechelen, België, 15 december 2020, 22.15 CET; gereglementeerde informatie – Gilead Sciences, Inc. (Nasdaq: GILD) en Galapagos...

Continue reading

State of Florida approves option agreement with Alico to acquire approximately 5,804 acres of Alico Ranch

FORT MYERS, Fla., Dec. 15, 2020 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) announces today that the State of Florida approved entering into an option agreement submitted by Alico which grants the State an option to purchase approximately 5,804 acres of Alico Ranch for approximately $14.6 million under the Florida Forever program.John Kiernan, Alico’s President and Chief Executive Officer, commented, “We are pleased the State of Florida has approved entering into this latest option agreement which grants it an option to purchase approximately 5,804 acres on the west side of the Alico Ranch. The 5,804 acre parcel is considered a primary and secondary zone for the federally endangered Florida panther and can contribute to increased protection of Florida’s biodiversity at the species, natural community, and landscape...

Continue reading

Senior Connect Acquisition Corp. I Announces Closing of $414 Million Upsized Initial Public Offering

Scottsdale, AZ, Dec. 15, 2020 (GLOBE NEWSWIRE) — Senior Connect Acquisition Corp. I (the “Company”) announced today the closing of its initial public offering of 41,400,000 units at a price of $10.00 per unit, including 5,400,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The units are listed on the Nasdaq Capital Market (“Nasdaq”) and began trading under the ticker symbol “SNRHU” on December 11, 2020.  Each unit consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share.  After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be...

Continue reading

Aspen Group Reports Year over Year Revenue Increase of 40% to a Record $17.0 Million in the Second Quarter Fiscal Year 2021, Raises Fiscal 2021 Revenue Growth Forecast by 300 Basis Points to 38%

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“Aspen Group” or “AGI”) (Nasdaq: ASPU), an education technology holding company, today announced financial results for its 2021 fiscal second quarter ended October 31, 2020.Second Quarter and Year to Date Fiscal Year 2021 Summary Results1 GAAP gross profit calculation includes marketing and promotional costs, instructional costs & services, and amortization expense.2 See reconciliations of GAAP to Non-GAAP financial measures under “Non-GAAP–Financial Measures” below.“Aspen Group’s consistent top-line performance is attributable to the focused execution of our growth strategy. Our high growth to date reflects our marketing spend prioritization to ramp enrollment in our high LTV degree programs. We have now begun executing...

Continue reading

DAVIDsTEA Reports Third Quarter Fiscal 2020 Financial Results

145.5% increase in e-commerce and wholesale sales to $22.1 millionGross profit of $10.8 millionAdjusted EBITDA of $3.3 millionCash of $21.9 million at quarter-endRestructuring activities ongoing and Court order extended until March 19, 2021MONTREAL, Dec. 15, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, announces its third quarter results for the period ended October 31, 2020. DAVIDsTEA also announces the appointment of Sarah Segal as Chief Executive Officer (CEO), in addition to her position as Chief Brand Officer, and Frank Zitella as President, in addition to his position as Chief Operating Officer and Chief Financial Officer (CFO). Herschel Segal will be stepping down as interim CEO and will remain Chairman of the Board of Directors. Frank Zitella...

Continue reading

Les Thés DAVIDsTEA annoncent leurs résultats financiers du troisième trimestre de l’exercice 2020

Hausse de 145,5 % des ventes générées par le commerce de gros et le commerce électronique, qui ont atteint 22,1 M$Bénéfice brut de 10,8 M$BAIIA ajusté de 3,3 M$Trésorerie nette de 21,9 M$ à la fin du trimestreActivités de restructuration en cours et ordonnance de la Cour prolongée jusqu’au 19 mars 2021MONTRÉAL, 15 déc. 2020 (GLOBE NEWSWIRE) — Les Thés DAVIDsTEA inc. (Nasdaq : DTEA) (« THÉS DAVIDsTEA » ou la « Société »), l’un des premiers marchands de thé en Amérique du Nord, annoncent leurs résultats du troisième trimestre pour la période se terminant le 31 octobre 2020. Les Thés DAVIDsTEA annoncent également la nomination de Sarah Segal au poste de chef de la direction, qui s’ajoute à son poste de chef de la marque, et de Frank Zitella au poste de président, qui s’ajoute à son poste de chef de l’exploitation et de...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.